Camerone Eleonora Maria, Battista Simone, Benedetti Fabrizio, Carlino Elisa, Sansone Lucia Grazia, Buzzatti Luca, Scafoglieri Aldo, Testa Marco
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genoa, Italy.
Department of Psychology, University of Milan-Bicocca, Milan, Italy.
Front Psychiatry. 2022 Mar 23;13:807138. doi: 10.3389/fpsyt.2022.807138. eCollection 2022.
The direction and the magnitude of verbal suggestions have been shown to be strong modulators of nocebo hyperalgesia, while little attention has been given to the role of their temporal content. Here, we investigate whether temporal suggestions modulate the timing of nocebo hyperalgesia in an experimental model of sustained pain.
Fifty-one healthy participants were allocated to one of three groups. Participants received an inert cream and were instructed that the agent had either hyperalgesic properties setting in after 5 (Nocebo 5, N5) or 30 (Nocebo 30, N30) minutes from cream application, or hydrating properties (No Expectation Group, NE). Pain was induced by the Cold Pressure Test (CPT) which was repeated before cream application (baseline) and after 10 (Test10) and 35 (Test35) minutes. Changes in pain tolerance and in HR at each test point in respect to baseline were compared between the three groups.
Tolerance change at Test 10 (Δ10) was greater in N5 (MED = -36.8; IQR = 20.9) compared to NE (MED = -5.3; IQR = 22.4; < 0.001) and N30 (MED = 0.0; IQR = 23.1; < 0.001), showing that hyperalgesia was only present in the group that expected the effect of the cream to set in early. Tolerance change at Test 35 (Δ35) was greater in N5 (MED = -36.3; IQR = 35.3; = 0.002) and in N30 (MED = -33.3; IQR = 34.8; = 0.009) compared to NE, indicating delayed onset of hyperalgesia in N30, and sustained hyperalgesia in N5. No group differences were found for HR.
Our study demonstrated that temporal expectations shift nocebo response onset in a model of sustained pain.
言语暗示的方向和强度已被证明是安慰剂性痛觉过敏的强效调节因素,而其时间内容的作用却很少受到关注。在此,我们在持续性疼痛的实验模型中研究时间暗示是否会调节安慰剂性痛觉过敏的发生时间。
51名健康参与者被分配到三组中的一组。参与者接受一种惰性乳膏,并被告知该制剂在涂抹乳膏后5分钟(安慰剂5组,N5)或30分钟(安慰剂30组,N30)后具有痛觉过敏特性,或者具有保湿特性(无预期组,NE)。通过冷压试验(CPT)诱发疼痛,在涂抹乳膏前(基线)、10分钟后(测试10)和35分钟后(测试35)重复进行。比较三组在每个测试点相对于基线的疼痛耐受性和心率变化。
与NE组(中位数=-5.3;四分位数间距=22.4;P<0.001)和N30组(中位数=0.0;四分位数间距=23.1;P<0.001)相比,N5组在测试10时的耐受性变化(Δ10)更大(中位数=-36.8;四分位数间距=20.9),表明痛觉过敏仅出现在预期乳膏效果早期出现的组中。与NE组相比,N5组(中位数=-36.3;四分位数间距=35.3;P=0.002)和N30组(中位数=-33.3;四分位数间距=34.8;P=0.009)在测试35时的耐受性变化更大,表明N30组痛觉过敏延迟出现,N5组痛觉过敏持续存在。在心率方面未发现组间差异。
我们的研究表明,在持续性疼痛模型中,时间预期会改变安慰剂反应的起始时间。